Accuracy Coverage Pricing Help Centre Contact
Vifor Pharma AG

Vifor Pharma AG (VIFN) Dividends

Dividend Summary:

The next Vifor Pharma AG dividend is expected to go ex in 8 months and to be paid in 8 months.
The previous Vifor Pharma AG dividend was 200c and it went ex 4 months ago and it was paid 4 months ago.
There is typically 1 dividend per year (excluding specials).
Country:
Switzerland
Exchange:
SIX Swiss Exchange
Sector:
Health Care Equipment & Services
  Previous Dividend Next Dividend
Status: Paid Forecast
Type: Final Final
Per Share: 200c Sign Up Required
Ex-div Date: Mon 18 May 2020 Mon 17 May 2021
Pay Date: Wed 20 May 2020 Wed 19 May 2021
Your Holding: 100 shares 100 shares
Your Payment: Fr.200.00 Sign Up Required

Dividend Payment Calculator

Enter the number of shares you hold:

shares
Calculate Payment

Free dividend email notifications

Declared and Forecast Vifor Pharma AG Dividends

Ex-Div Date Pay Date Type Amount Currency Status
06 May 2013 10 May 2013 Final 1100c CHF Paid
13 May 2014 16 May 2014 Final 1400c CHF Paid
12 May 2015 15 May 2015 Final 1500c CHF Paid
03 May 2016 06 May 2016 Final 1800c CHF Paid
16 May 2017 18 May 2017 Final 2000c CHF Paid
17 May 2018 22 May 2018 Final 200c CHF Paid
10 May 2019 14 May 2019 Final 200c CHF Paid
18 May 2020 20 May 2020 Final 200c CHF Paid
17 May 2021 19 May 2021 Final Sign Up Required CHF Forecast
16 May 2022 18 May 2022 Final Sign Up Required CHF Forecast
15 May 2023 17 May 2023 Final Sign Up Required CHF Forecast
13 May 2024 15 May 2024 Final Sign Up Required CHF Forecast
12 May 2025 14 May 2025 Final Sign Up Required CHF Forecast

How accurate are our Vifor Pharma AG forecasts?

Prediction Date Dividend Date Forecast Amount Actual Amount Accuracy
17 Apr 2019 18 May 2020 200c 200c 100% 😄
Average Vifor Pharma AG Forecast Accuracy 100% 😄

Access our Vifor Pharma AG dividend forecasts and the suite of investor tools free for 30 days.

Try DividendMax free for 30 days

About Vifor Pharma AG

Vifor Pharma AG, formerly known as Galenica AG, is a Switzerland-based company engaged in the healthcare market. The Company operates through a single pharmaceutical segment. It develops, manufactures and markets pharmaceutical products, specializing in therapies for iron deficiency, nephrology and cardio-renal diseases. The Company's portfolio of iron deficiency treatments includes intravenous products, Ferinject and Venofer, and oral product, Maltofer, among others. Its portfolio of renal pharmaceuticals includes products for anaemia management, such as Mircera, mineral and bone management, such as Velphoro, Rayaldee and Osvaren, and cardio-renal management, such as patiromer (in the United States sold under the brand Veltassa). The Company also conducts research in the area of infectious and rare diseases, partnering with other biopharmaceutical companies. The Company has production sites in Switzerland and Portugal as well as a network of affiliates and partners around the world.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0c
2007 0.0c 0%
2008 0.0c 0%
2009 0.0c 0%
2010 0.0c 0%
2011 0.0c 0%
2012 1100.0c 100%
2013 1400.0c 27.3%
2014 1500.0c 7.1%
2015 1800.0c 20.0%
2016 2000.0c 11.1%
2017 200.0c (90.0%)
2018 200.0c 0%
2019 200.0c 0%
2020 Login required
2021 Login required
2022 Login required
2023 Login required
2024 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount
06 May 2013 10 May 2013 2012 Final Annually Paid 1100c
13 May 2014 16 May 2014 2013 Final Annually Paid 1400c
12 May 2015 15 May 2015 2014 Final Annually Paid 1500c
03 May 2016 06 May 2016 2015 Final Annually Paid 1800c
16 May 2017 18 May 2017 2016 Final Annually Paid 2000c
17 May 2018 22 May 2018 2017 Final Annually Paid 200c
10 May 2019 14 May 2019 2018 Final Annually Paid 200c
18 May 2020 20 May 2020 2019 Final Annually Paid 200c
Sign Up Required Sign Up Required 2020 Final Annually Forecast Sign Up Required
Sign Up Required Sign Up Required 2021 Final Annually Forecast Sign Up Required
Sign Up Required Sign Up Required 2022 Final Annually Forecast Sign Up Required
Sign Up Required Sign Up Required 2023 Final Annually Forecast Sign Up Required
Sign Up Required Sign Up Required 2024 Final Annually Forecast Sign Up Required

Vifor Pharma AG optimized dividend - 12 month history